Author Correction: IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity

• Elisa Landoni,
• Mark G. Woodcock,
• Gabriel Barragan,
• Gabriele Casirati,
• Vincenzo Cinella,
• Simone Stucchi,
• Leah M. Flick,
• Tracy A. Withers,
• Hanna Hudson,
• Giulia Casorati,
• Paolo Dellabona,
• Pietro Genovese,
• Barbara Savoldo,
• Leonid S. Metelitsa,
• Gianpietro Dotti

Affiliations

Elisa Landoni

Lineberger Comprehensive Cancer Center, University of North Carolina

Mark G. Woodcock

Lineberger Comprehensive Cancer Center, University of North Carolina

Gabriel Barragan

Center for Advanced Innate Cell Therapy, Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine

Gabriele Casirati

Dana-Farber/Boston Children’s Cancer and Blood Disorder Center

Vincenzo Cinella

Dana-Farber/Boston Children’s Cancer and Blood Disorder Center

Simone Stucchi

Lineberger Comprehensive Cancer Center, University of North Carolina

Leah M. Flick

Lineberger Comprehensive Cancer Center, University of North Carolina

Tracy A. Withers

Lineberger Comprehensive Cancer Center, University of North Carolina

Hanna Hudson

Lineberger Comprehensive Cancer Center, University of North Carolina

Giulia Casorati

Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute

Paolo Dellabona

Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute

Pietro Genovese

Dana-Farber/Boston Children’s Cancer and Blood Disorder Center

Barbara Savoldo

Lineberger Comprehensive Cancer Center, University of North Carolina

Leonid S. Metelitsa

Center for Advanced Innate Cell Therapy, Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine

Gianpietro Dotti

Lineberger Comprehensive Cancer Center, University of North Carolina